Oculis Holding AG (OCS) stock
OCSNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as OCSAW
$7.39−0.12 (-1.60%)
Close on Nov 18, 2026Market cap $444.06MP/E –Yield –
Oculis shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Oculis's shares outstanding was 61M at Jun 30, 2026. For fiscal 2025 it was 52M, up 29.3% from the year before. The highest annual figure on record is 52M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 52M | +29.3% |
| FY2024 | Dec 31, 2024 | 40M | +35.1% |
| FY2023 | Dec 31, 2023 | 30M | +900.2% |
| FY2022 | Dec 31, 2022 | 3M | +7.6% |
| FY2021 | Dec 31, 2021 | 3M | +7.7% |
| FY2020 | Dec 31, 2020 | 3M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 61M | – |
| Q2 FY2025 | Jun 30, 2025 | 52M | – |
| Q2 FY2024 | Jun 30, 2024 | 41M | – |
| Q2 FY2023 | Jun 30, 2023 | 34M | – |
See a number that looks wrong?